Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-07

FDA Approved: AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Macleods' generic fixed-dose combination tablet of amlodipine, valsartan, and hydrochlorothiazide for hypertension under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (amlodipine/valsartan/hydrochlorothiazide)

Snippet

ORIG AP for AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE (AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE)